Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is a highly aggressive disease with a dismal prognosis. The recently described role of RNA pseudouridine modification in regulating anti-tumor immunity has attracted interest, but the understanding of its impact on hepatocellular carcinoma progression and immu...
Saved in:
| Main Authors: | Weifeng Xu, Caiyun Nie, Zhen Liu, Yingjun Liu, Penghui Yu, Huifang Lv, Beibei Chen, Jianzheng Wang, Saiqi Wang, Jing Zhao, Yunduan He, Shegan Gao, Xiaobing Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cancer Cell International |
| Online Access: | https://doi.org/10.1186/s12935-025-03844-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
by: Beibei Chen, et al.
Published: (2025-04-01) -
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
by: Shiheng Jia, et al.
Published: (2025-01-01) -
Protocol for differential analysis of pseudouridine modifications using nanopore DRS and unmodified transcriptome control
by: Oleksandra Fanari, et al.
Published: (2025-09-01) -
Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways
by: Li Chen, et al.
Published: (2025-03-01) -
Quantitative detection of pseudouridine in RNA by mass spectrometry
by: Shanice Jessica Hermon, et al.
Published: (2024-11-01)